Merck has been vocal about its desire for dealmaking, saying as far back as January 2024 that it was willing to spend up to $15 billion. Any deals, especially for companies with l …
This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy
view original post